RU2005128132A - Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов - Google Patents
Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов Download PDFInfo
- Publication number
- RU2005128132A RU2005128132A RU2005128132/14A RU2005128132A RU2005128132A RU 2005128132 A RU2005128132 A RU 2005128132A RU 2005128132/14 A RU2005128132/14 A RU 2005128132/14A RU 2005128132 A RU2005128132 A RU 2005128132A RU 2005128132 A RU2005128132 A RU 2005128132A
- Authority
- RU
- Russia
- Prior art keywords
- bacterial diseases
- solid
- fluorochinolons
- local application
- treatment
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title claims 3
- 230000000241 respiratory effect Effects 0.000 title 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 208000019693 Lung disease Diseases 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 229960003237 betaine Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 229950005627 embonate Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (7)
1. Способ борьбы с бактериальными заболеваниями органов дыхания людей и животных путем местного применения антибактериально эффективного количества твердого бетаина формулы (III)
R=Н, C2H5
и/или его твердой труднорастворимой соли.
2. Способ по п.1 для борьбы с бактериально обусловленными легочными болезнями.
3. Способ по п.1 или 2 путем локального применения антибактериально эффективного количества твердого бетаина формулы (III) по п.1 и/или его эмбоната.
4. Применение соединений по п.1 или 3 для получения лекарственных средств, предназначенных для местной борьбы с бактериальными заболеваниями органов дыхания людей и животных, причем указанные соединения применяют в твердом состоянии.
5. Применение по п.4 для получения лекарственных средств, предназначенных для местной борьбы с бактериально обусловленными легочными болезнями.
6. Устройства, пригодные для ингаляционного применения твердого биологически активного вещества и включающие лекарственные препараты, содержащие соединения по меньшей мере одному из п.1 или 3.
7. Устройства по п.6, выполненные в виде ингаляторов порошков.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10305319A DE10305319A1 (de) | 2003-02-10 | 2003-02-10 | Behandlung bakteriell verursachter Lungenkrankheiten |
| DE10305319.0 | 2003-02-10 | ||
| DE10305318.2 | 2003-02-10 | ||
| DE10305318A DE10305318A1 (de) | 2003-02-10 | 2003-02-10 | Behandlung bakteriell verursachter Lungenkrankheiten |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2005128132A true RU2005128132A (ru) | 2006-02-10 |
| RU2373937C2 RU2373937C2 (ru) | 2009-11-27 |
| RU2373937C9 RU2373937C9 (ru) | 2010-07-27 |
Family
ID=32851853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005128132/14A RU2373937C9 (ru) | 2003-02-10 | 2004-01-28 | Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8034817B2 (ru) |
| EP (1) | EP1594500B1 (ru) |
| JP (2) | JP4828405B2 (ru) |
| KR (1) | KR101173696B1 (ru) |
| AR (1) | AR043117A1 (ru) |
| AT (1) | ATE482706T1 (ru) |
| AU (1) | AU2004210399B2 (ru) |
| BR (1) | BRPI0407368A (ru) |
| CA (1) | CA2515262C (ru) |
| CY (1) | CY1110998T1 (ru) |
| DE (1) | DE502004011696D1 (ru) |
| DK (1) | DK1594500T3 (ru) |
| EC (1) | ECSP055959A (ru) |
| HR (1) | HRP20050786B1 (ru) |
| IL (1) | IL170027A (ru) |
| MA (1) | MA27632A1 (ru) |
| MX (1) | MXPA05008407A (ru) |
| MY (1) | MY144714A (ru) |
| NO (1) | NO331524B1 (ru) |
| NZ (1) | NZ541681A (ru) |
| PE (1) | PE20050189A1 (ru) |
| PT (1) | PT1594500E (ru) |
| RU (1) | RU2373937C9 (ru) |
| SI (1) | SI1594500T1 (ru) |
| TW (1) | TWI347843B (ru) |
| UY (1) | UY28179A1 (ru) |
| WO (1) | WO2004069253A1 (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7157455B2 (en) * | 2003-02-10 | 2007-01-02 | Hoffmann-La Roche Inc. | 4-Aminopyrimidine-5-one derivatives |
| ATE482706T1 (de) * | 2003-02-10 | 2010-10-15 | Bayer Schering Pharma Ag | Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen |
| WO2006033713A2 (en) * | 2004-08-09 | 2006-03-30 | Chiron Corporation | Methods for ciprofloxacin inhalation |
| US8846607B2 (en) | 2004-10-29 | 2014-09-30 | President And Fellows Of Harvard College | Particles for treatment of pulmonary infection |
| DK1901749T3 (en) * | 2005-05-18 | 2016-10-24 | Raptor Pharmaceuticals Inc | Aerosolized fluoroquinolones AND USES THEREOF |
| US8524735B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| KR101621986B1 (ko) * | 2008-05-15 | 2016-05-17 | 노파르티스 아게 | 플루오로퀴놀론의 폐 전달 |
| US8815838B2 (en) | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| CA2739893C (en) | 2008-10-07 | 2016-10-04 | Mpex Pharmaceuticals, Inc. | Inhalation of levofloxacin for reducing lung inflammation |
| US8168597B2 (en) | 2008-10-22 | 2012-05-01 | Inspire Pharmaceuticals, Inc. | Method for treating cystic fibrosis |
| EP3569235A1 (en) | 2009-09-04 | 2019-11-20 | Horizon Orphan LLC | Use of aerosolized levofloxacin for treating cystic fibrosis |
| US9393243B1 (en) | 2015-07-14 | 2016-07-19 | Nilesh Parikh | Topical Ciprofloxacin compositions |
| WO2018074880A2 (ko) * | 2016-10-20 | 2018-04-26 | 한국화학연구원 | 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
| DE3033157A1 (de) | 1980-09-03 | 1982-04-01 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| DE3525335A1 (de) * | 1985-07-16 | 1987-01-22 | Bayer Ag | Embonate von chinoloncarbonsaeuren und ihren derivaten |
| DE3906365A1 (de) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| FR2655545B1 (fr) * | 1989-12-11 | 1994-06-10 | Rhone Poulenc Sante | Nouvelle application therapeutique des derives des fluoroquinolones. |
| EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
| DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| RU2063770C1 (ru) * | 1992-05-22 | 1996-07-20 | Николай Сергеевич Скрипников | Способ лечения гнойно-воспалительных заболеваний легких |
| RU2070045C1 (ru) * | 1993-01-15 | 1996-12-10 | Вячеслав Михайлович Провоторов | Способ лечения хронического гнойного эндобронхита |
| DE19633480A1 (de) * | 1996-08-20 | 1998-02-26 | Bayer Ag | Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren |
| DE19812160C1 (de) * | 1998-03-20 | 1999-07-08 | Bayer Ag | Formkörper aus wirkstoffhaltigen thermoplastischen Polyurethanen |
| AU5528299A (en) * | 1998-09-15 | 2000-04-03 | Naeja Pharmaceutical Inc. | Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s) |
| CN1188111C (zh) * | 1999-10-29 | 2005-02-09 | 耐科塔医药公司 | 分散性得到改进的干粉组合物 |
| DE19962470A1 (de) | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
| WO2003075889A1 (en) * | 2002-03-05 | 2003-09-18 | Transave, Inc. | An inhalation system for prevention and treatment of intracellular infections |
| CA2483218C (en) * | 2002-04-25 | 2012-07-10 | Nektar Therapeutics Uk Ltd | Particulate materials |
| ATE482706T1 (de) * | 2003-02-10 | 2010-10-15 | Bayer Schering Pharma Ag | Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen |
-
2004
- 2004-01-28 AT AT04705765T patent/ATE482706T1/de active
- 2004-01-28 RU RU2005128132/14A patent/RU2373937C9/ru not_active IP Right Cessation
- 2004-01-28 MX MXPA05008407A patent/MXPA05008407A/es active IP Right Grant
- 2004-01-28 SI SI200431572T patent/SI1594500T1/sl unknown
- 2004-01-28 NZ NZ541681A patent/NZ541681A/en not_active IP Right Cessation
- 2004-01-28 EP EP04705765A patent/EP1594500B1/de not_active Expired - Lifetime
- 2004-01-28 AU AU2004210399A patent/AU2004210399B2/en not_active Ceased
- 2004-01-28 KR KR1020057014646A patent/KR101173696B1/ko not_active Expired - Fee Related
- 2004-01-28 CA CA2515262A patent/CA2515262C/en not_active Expired - Fee Related
- 2004-01-28 DK DK04705765.8T patent/DK1594500T3/da active
- 2004-01-28 PT PT04705765T patent/PT1594500E/pt unknown
- 2004-01-28 DE DE502004011696T patent/DE502004011696D1/de not_active Expired - Lifetime
- 2004-01-28 HR HRP20050786AA patent/HRP20050786B1/hr not_active IP Right Cessation
- 2004-01-28 JP JP2006501628A patent/JP4828405B2/ja not_active Expired - Fee Related
- 2004-01-28 WO PCT/EP2004/000710 patent/WO2004069253A1/de not_active Ceased
- 2004-01-28 BR BRPI0407368-1A patent/BRPI0407368A/pt not_active Application Discontinuation
- 2004-02-06 MY MYPI20040367A patent/MY144714A/en unknown
- 2004-02-06 AR ARP040100382A patent/AR043117A1/es unknown
- 2004-02-06 UY UY28179A patent/UY28179A1/es not_active Application Discontinuation
- 2004-02-09 PE PE2004000145A patent/PE20050189A1/es not_active Application Discontinuation
- 2004-02-09 TW TW093102878A patent/TWI347843B/zh not_active IP Right Cessation
- 2004-02-10 US US10/775,888 patent/US8034817B2/en not_active Expired - Fee Related
-
2005
- 2005-08-02 IL IL170027A patent/IL170027A/en active IP Right Grant
- 2005-08-10 EC EC2005005959A patent/ECSP055959A/es unknown
- 2005-09-08 NO NO20054180A patent/NO331524B1/no not_active IP Right Cessation
- 2005-09-09 MA MA28491A patent/MA27632A1/fr unknown
-
2010
- 2010-12-17 CY CY20101101161T patent/CY1110998T1/el unknown
-
2011
- 2011-06-08 JP JP2011128600A patent/JP2011173929A/ja active Pending
- 2011-07-28 US US13/192,893 patent/US20120010215A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2005128132A (ru) | Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов | |
| BR0015908A (pt) | Emprego de compostos org nicos no tratamento de doenças | |
| BR0013116B1 (pt) | formulaÇÕes orais de dose énica para controlar infestaÇço por ectoparasita em animais de estimaÇço, e seu uso. | |
| BR0307356A (pt) | Misturas inseticidas sinergìsticas | |
| JP2005517714A5 (ru) | ||
| HRP20100552T1 (hr) | Agonisti beta-2 adrenoceptora za liječenje kožnih bolesti vezivnog tkiva | |
| JP2022527359A (ja) | 媒介動物媒介性疾患およびウイルス性疾患の治療または予防のための全身性イソキサゾリン系寄生虫駆除剤 | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| FR2858556B1 (fr) | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation | |
| BR0307834A (pt) | Misturas inseticidas sinergìsticas | |
| RU2107502C1 (ru) | Ветеринарный препарат, обладающий широким спектром действия, - йод однохлористый | |
| ES2771599T3 (es) | Composición tópica que comprende extractos de boldo y de reina de los prados, destinada a un animal, y sus aplicaciones | |
| JP2005517713A5 (ru) | ||
| Elhawary et al. | A trial of doramectin injection and ivermectin spot-on for treatment of rabbits artificially infested with the ear mite “Psoroptes cuniculi” | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
| RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
| DK1196439T3 (da) | Forbindelser udvisende en antibiotikaaktivitet | |
| ATE551056T1 (de) | Mittel zur hemmung der körpergewichtszunahme | |
| DE602004011842D1 (de) | Die funktion der atmungsorgane wiederherstellende peptidsubstanz | |
| DE60201022T2 (de) | Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode | |
| NL1024714C1 (nl) | Farmaceutische samenstelling en keelspray op basis van een zinkzout. | |
| JP2006504751A5 (ru) | ||
| DE10227148A1 (de) | Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae | |
| JP2002338414A5 (ru) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH4A | Reissue of patent specification | ||
| PD4A | Correction of name of patent owner | ||
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20130806 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20190129 |